← Back to PTHS

Pelthos Therapeutics Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$16$11$0.3$0$0
−$23−$25−$16−$3.4−$2−$1.7−$1.8−$2.6
−$6.62−$7.57−$5.30−$5.29−$3.21−$2.93−$3.07−$0.55
3.53.33.10.70.60.60.64.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.